Handok introduces Australia’s top nasal spray in Korea, expanding OTC business
The Handok’s OTC business has started to bear fruits. Handok which acquired an arthritis treatment ‘Ketotop’ through acquiring Pacific Pharmaceuticals succeeded in acquiring the Australia’s top nasal spray brand ‘FESS’ in the first half of the year.
According to the industry on the 17th, Handok ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
